Behavioural disorders in Alzheimer's disease. Data from a populational study;Alteraciones del comportamiento en la enfermedad de Alzheimer. Datos de un estudio poblacional

Revista de Neurologia

Volumn 38, Issue 10, 2004, Pages 901-905

  De Toledo, Maria ^a   Bermejo Pareja, F ^b   Vega Quiroga, S ^c   Munoz Garcia D ^d  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c Health Center of Arévalo   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Affective disorders; Alzheimer disease; Behavior; Delusions; Dementia; Depression; Hallucinations; Neuropsychological tests; Psychotic disorders

Indexed keywords

CHOLINESTERASE INHIBITOR; PSYCHOTROPIC AGENT;

AGED; AGITATION; ALZHEIMER DISEASE; ANXIETY; APATHY; APPETITE DISORDER; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; DELIRIUM; DISEASE SEVERITY; DYSPHORIA; EATING DISORDER; EUPHORIA; FEMALE; FUNCTIONAL DISEASE; HALLUCINATION; HUMAN; INTERVIEW; IRRITABILITY; LONGITUDINAL STUDY; MALE; MOTOR ACTIVITY; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; POPULATION RESEARCH;

EID: 3142690662     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3810.2003520     Document Type: Article

References (37)

1. Folstein MF, Bylsma. FW. Noncognitive symptoms of Alzheimer disease. In Terry RD, Katzman R, Bick KL, Sisodia SS, eds. Alzheimer disease. 2 ed. Philadelphia: Lippincott Williams & Wilkins; 1999.
2. Borson S, Raskind M. Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease. Neurology 1997; 48 (Suppl 6): S17-24.
3. Wilson R, Gilley DW, Bennett DA, Beckett LA, Evans DA. Hallucinations, delusions, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000; 69: 172-7.
4. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996; 46: 130-5.
5. Alberca R, Gil-Eciga E, Salas D, Pérez JA, Lozano P. Síntomas psicóticos y enfermedad de Alzheimer. Neurología 2000; 15: 8-14.
6. Vilalta-Franch J, López-Pousa S, Llinás-Reglá J. Prevalencia de los trastornos depresivos en la demencia. Rev Neurol 1998; 26: 57-60.
7. Cummings LJ, Victoroff JI. Noncognitive neuropsychiatric syndroms in Alzheimer's disease. Neuropsychiatr Neuropsychol Behav Neurol 1990; 3: 140-58.
8. Teri L, Larson EB, Reifler BV. Behavioral disturbance in dementia of the Alzheimer's type. J Am Geriatr Soc 1988; 36: 1-6.
9. Gotlieb GL, Gur RE. Reliability of psychiatric scales in patients with dementia of the Alzheimer's type. Am J Pshychiatry 1988; 145: 857-60.
10. Cummings JL, Ross W, Absher J, Gornbein J, Hadjiaghai L. Depressive symptoms in Alzheimer's disease: assessment and determinants. Alzheimer Dis Assoc Disord 1995; 9: 87-93.
11. Bermejo F, Morales JM. Dementia and door-to-door studies in Spain. J Neurol Neurosurg Psychiatry 1994; 57: 874.
12. Benito-León J, Bermejo-Pareja F, Morales JM, Vega S, Molina JA. Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord 2003; 18: 389-94.
13. Benito-León J, Bermejo-Pareja F, Rodríguez J, Molina JA, Gabriel I, Morales JM. Prevalence of PD and other types of Parkinsonism in three elderly populations of central Spain. Mov Disord 2003; 18: 267-74.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
15. Folstein MF, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for clinician. J Psychiatry Rev 1975; 12: 186-98.
16. Lobo A, Ezquerra J, Gómez-Bugada FG, Sala JM, Seva-Díaz A. El Mini-examen cognoscitivo (un test sencillo, práctico, para detectar alteraciones intelectuales en pacientes médicos). Actas Luso Esp Neurol Psiquiatr 1979; 7: 189-202.
17. Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filois S. Measurement on functional activities in older adults in the community. J Gerontol 1982; 37: 323-9.
18. Böhm P, Peña-Casanova J, Aguilar M, Hernández G, Sol JM, Blesa R. Clinical validity and utility of the interview for deterioration of daily living in dementia for Spanish-speaking communities. Int Psychogeriatr 1998; 10: 261-70.
19. Teunisse S, Derix M, Van Crevel H. Assessing the severity of dementia. Arch Neurol 1991; 48: 274-7.
20. Hughes CP, Berg L, Danzinger W, Chi D, Jost G. A new clinical scale for the staging of dementia. Br Psychiatr 1988; 140: 5666-72.
21. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gombein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-14.
22. Cummings JL. The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology 1997; 48: S10-6.
23. Vilalta-Franch J, Lozano-Gallego M, Hernandez-Ferrándiz M, Llinás-Reglá J, López-Pousa S, López OL. Neuropsychiatric Inventory. Propiedades psicométricas de su adaptación al español. Rev Neurol 1999; 29: 15-9.
24. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression scale: a preliminary report. J Psychiatr Res 1983; 17: 37-49.
25. Shiekh J, Yesavage J. Geriatric Depression Scale, recent findings and development of a short version. In Brink T, ed. Clinical gerontology: a guide to assessment and intervention. New York: Howarth Press; 1986.
26. Martin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the apathy evaluation scale. Psychiatry Res 1991; 38: 143-62.
27. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, et al. Apathy is not depression. Neuropsychiatry Clin Neurosci 1998; 10: 314-9.
28. Kuzis G, Sabe L, Tiberti C, Dorrego F, Starkstein SE. Neuropsychological correlates of apathy and depression in patients with dementia. Neurology 1999; 52: 1403-7.
29. Starkstein SE, Petracca G, Chemerinski E, Kramer J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 2001; 158: 872-7.
30. Binetti G, Mega MS, Magni E, Padovani A, Rozzini L, Bianchetti A, et al. Behavioral disorders in Alzheimer's disease: a transcultural perspective. Arch Neurol 1998; 55: 539-44.
31. Cummings JL, Díaz C, Levy M, Binetti G, Litvan II. Neuropsychiatric syndromes in neurodegenerative diseases: frequency and significance. Semin Neuropsychiatry 1996; 1: 241-7.
32. Levy ML, Miller BL, Cummings JL, Fairbanks LA. Craig A. Alzheimer disease and frontotemporal dementias: behavioral distinctions. Arch Neurol 1996; 53: 687-90.
33. Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol Aging 2000; 21: 845-61.
34. Kaufer D. Tratamiento de los síntomas neuropsiquiátricos en la enfermedad de Alzheimer. Rev Neurol 2002; 35: 846-50.
35. Mega MS, Masterman DM, O'Connor SM, Barclay TR, Cummings JL. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer's disease. Arch Neurol 1999; 56: 1388-93.
36. Levy ML, Cummings JL, Kahn-Rose R. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease. Gerontology 1999; 45 (Suppl 1): 15-22.
37. Street JS, Clark WS, Gannon KS. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double blind, randomized, placebo-controlled trial. The HGEU Study Group. Arch Gen Psychiatry 2000; 57: 968-76.